Posted in | News | Nanomedicine

Arrowhead to Discuss its Nanomedicine Portfolio at Bio Investor Forum

Related Stories

Arrowhead Research Corporation (NASDAQ:ARWR) today announced that Dr. Christopher Anzalone, Chief Executive Officer, will be presenting at the 9th Annual BIO Investor Forum at 4:30 p.m. PT on Tuesday, October 5, 2010, at the Palace Hotel in San Francisco, CA.

Dr. Anzalone will be discussing the Company and its increased focus on its nanomedicine portfolio, including clinical results.

The BIO Investor Forum is a national investor conference featuring private and emerging public companies. The meeting attracts healthcare venture capital and public market investors and research analysts. In addition, the BIO Investor Forum draws business development executives from global pharmaceutical and biotechnology companies.

Source: http://www.arrowheadresearch.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Arrowhead Pharmaceutical. (2019, February 13). Arrowhead to Discuss its Nanomedicine Portfolio at Bio Investor Forum. AZoNano. Retrieved on December 03, 2024 from https://www.azonano.com/news.aspx?newsID=19751.

  • MLA

    Arrowhead Pharmaceutical. "Arrowhead to Discuss its Nanomedicine Portfolio at Bio Investor Forum". AZoNano. 03 December 2024. <https://www.azonano.com/news.aspx?newsID=19751>.

  • Chicago

    Arrowhead Pharmaceutical. "Arrowhead to Discuss its Nanomedicine Portfolio at Bio Investor Forum". AZoNano. https://www.azonano.com/news.aspx?newsID=19751. (accessed December 03, 2024).

  • Harvard

    Arrowhead Pharmaceutical. 2019. Arrowhead to Discuss its Nanomedicine Portfolio at Bio Investor Forum. AZoNano, viewed 03 December 2024, https://www.azonano.com/news.aspx?newsID=19751.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback